Nanjing Well Pharmaceutical Co Ltd (603351)

Shanghai
Currency in CNY
29.29
+0.18(+0.62%)
Closed·
603351 Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
603351 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
28.9629.60
52 wk Range
18.8133.34
Key Statistics
Edit
Bid/Ask
29.34 / 29.35
Prev. Close
29.11
Open
29.16
Day's Range
28.96-29.6
52 wk Range
18.81-33.34
Volume
2.13M
Average Volume (3m)
3.43M
1-Year Change
45.27%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603351 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 7 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Nanjing Well Pharma Company Profile

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables. The company also provides synthetic base oils, such as hydraulic fluids, lubricity additives for metals, metal quenching, base fluids and lubricity additives, synthetic base for compress lubricants, synthetic base oil for gear, base oil of chain lubricants, base stock of engine oil, base stock of heat transfer oil, and base oil of grease; and other products, including painting and coating, textile chemicals, field chemicals, and low foam metal cleaners. In addition, it engages in the manufacturing of bio-based materials; research and development, production, and sales of feed additives; technology research and development of bio-based materials; and research and development, and manufacturing of electronic special materials, as well as technical development, technical consultation, and technical services. The company also exports its products to Europe, the United States, Southeast Asia, and internationally. The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020. Nanjing Well Pharmaceutical Group Co.,Ltd. was founded in 2000 and is based in Nanjing, China.

Industry
Oil & Gas
Sector
Energy
Employees
711
Market
China

Compare 603351 to Peers and Sector

Metrics to compare
603351
Peers
Sector
Relationship
P/E Ratio
26.6x31.4x2.1x
PEG Ratio
1.180.340.00
Price/Book
2.3x2.0x1.6x
Price / LTM Sales
3.0x3.6x1.3x
Upside (Analyst Target)
-14.1%22.0%
Fair Value Upside
Unlock8.7%2.3%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.09%
Dividend Yield
1.37%
Industry Median 7.49%
Annualised payout
0.40
Paid annually
5-Years Growth
+4.47%
Growth Streak

Earnings

Latest Release
Apr 21, 2025
EPS / Forecast
0.27 / --
Revenue / Forecast
349.73M / --
EPS Revisions
Last 90 days

603351 Income Statement

FAQ

What Is the Nanjing Well Pharma (603351) Stock Price Today?

The Nanjing Well Pharma stock price today is 29.29.

What Stock Exchange Does Nanjing Well Pharma Trade On?

Nanjing Well Pharma is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Nanjing Well Pharma?

The stock symbol for Nanjing Well Pharma is "603351."

Does Nanjing Well Pharma Pay Dividends? What’s The Current Dividend Yield?

The Nanjing Well Pharma dividend yield is 1.37%.

What Is the Nanjing Well Pharma Market Cap?

As of today, Nanjing Well Pharma market cap is 3.97B.

What Is Nanjing Well Pharma's Earnings Per Share (TTM)?

The Nanjing Well Pharma EPS (TTM) is 1.09.

From a Technical Analysis Perspective, Is 603351 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Nanjing Well Pharma Stock Split?

Nanjing Well Pharma has split 2 times.

How Many Employees Does Nanjing Well Pharma Have?

Nanjing Well Pharma has 711 employees.

What is the current trading status of Nanjing Well Pharma (603351)?

As of 10 Jul 2025, Nanjing Well Pharma (603351) is trading at a price of 29.29, with a previous close of 29.11. The stock has fluctuated within a day range of 28.96 to 29.60, while its 52-week range spans from 18.81 to 33.34.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.